| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutics | Chief Financial Officer | Class A ordinary shares, par value $0.0001 per share | 1,276,305 | $16,807,660 | $13.17 | 07 Jan 2026 | Direct |
| MoonLake Immunotherapeutics | Chief Financial Officer | Class C ordinary shares, par value $0.0001 per share | 0 | 19 Dec 2025 | Direct | ||
| MoonLake Immunotherapeutics | Chief Financial Officer | Common shares, par value CHF 0.10 per share, of MoonLake AG | 0 | 19 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | 07 Jan 2026 | 1 | $0 | 4 | Chief Financial Officer | 09 Jan 2026, 16:01 |
| MLTX | MoonLake Immunotherapeutics | 19 Dec 2025 | 3 | $0 | 4 | Chief Financial Officer | 22 Dec 2025, 16:02 |
| MLTX | MoonLake Immunotherapeutics | 08 Oct 2025 | 1 | +$98,808 | 4 | Chief Financial Officer | 09 Oct 2025, 09:01 |
| MLTX | MoonLake Immunotherapeutics | 27 Feb 2025 | 1 | $0 | 4 | Chief Financial Officer | 03 Mar 2025, 21:06 |
| MLTX | MoonLake Immunotherapeutics | 19 Dec 2023 | 2 | -$5,917,368 | 4 | Chief Financial Officer | 21 Dec 2023, 16:01 |
| MLTX | MoonLake Immunotherapeutics | 01 Oct 2023 | 3 | $0 | 4 | Chief Financial Officer | 03 Oct 2023, 19:30 |
| MLTX | MoonLake Immunotherapeutics | 05 Apr 2023 | 6 | $0 | 4 | Chief Financial Officer | 07 Apr 2023, 16:05 |
| MLTX | MoonLake Immunotherapeutics | 05 Apr 2022 | 0 | $0 | 3 | Chief Financial Officer | 15 Apr 2022, 16:06 |